Correlation Between AnaptysBio and Kymera Therapeutics
Can any of the company-specific risk be diversified away by investing in both AnaptysBio and Kymera Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining AnaptysBio and Kymera Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between AnaptysBio and Kymera Therapeutics, you can compare the effects of market volatilities on AnaptysBio and Kymera Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in AnaptysBio with a short position of Kymera Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of AnaptysBio and Kymera Therapeutics.
Diversification Opportunities for AnaptysBio and Kymera Therapeutics
0.1 | Correlation Coefficient |
Average diversification
The 3 months correlation between AnaptysBio and Kymera is 0.1. Overlapping area represents the amount of risk that can be diversified away by holding AnaptysBio and Kymera Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Kymera Therapeutics and AnaptysBio is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on AnaptysBio are associated (or correlated) with Kymera Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Kymera Therapeutics has no effect on the direction of AnaptysBio i.e., AnaptysBio and Kymera Therapeutics go up and down completely randomly.
Pair Corralation between AnaptysBio and Kymera Therapeutics
Given the investment horizon of 90 days AnaptysBio is expected to under-perform the Kymera Therapeutics. In addition to that, AnaptysBio is 2.43 times more volatile than Kymera Therapeutics. It trades about -0.1 of its total potential returns per unit of risk. Kymera Therapeutics is currently generating about -0.05 per unit of volatility. If you would invest 4,908 in Kymera Therapeutics on August 27, 2024 and sell it today you would lose (206.00) from holding Kymera Therapeutics or give up 4.2% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
AnaptysBio vs. Kymera Therapeutics
Performance |
| Timeline |
| AnaptysBio |
| Kymera Therapeutics |
AnaptysBio and Kymera Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with AnaptysBio and Kymera Therapeutics
The main advantage of trading using opposite AnaptysBio and Kymera Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if AnaptysBio position performs unexpectedly, Kymera Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Kymera Therapeutics will offset losses from the drop in Kymera Therapeutics' long position.| AnaptysBio vs. Crinetics Pharmaceuticals | AnaptysBio vs. Rhythm Pharmaceuticals | AnaptysBio vs. Kura Oncology | AnaptysBio vs. CytomX Therapeutics |
| Kymera Therapeutics vs. Foghorn Therapeutics | Kymera Therapeutics vs. Shattuck Labs | Kymera Therapeutics vs. Monte Rosa Therapeutics | Kymera Therapeutics vs. Nurix Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.
Other Complementary Tools
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes |